ESR1 and breast carcinoma: Thus, receptor ligands such as fluorine-labelled estradiol offer the possibility to study the presence of estrogen receptors (ER) in both primary and tumour metastasis, and may be a useful tool in the therapeutic management and prognostic evaluation of breast cancer.